Glaukos Corp (GKOS)
144.40
+3.57
(+2.53%)
USD |
NYSE |
Nov 22, 12:19
Glaukos Total Assets (Quarterly): 926.54M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 926.54M |
| June 30, 2024 | 919.68M |
| March 31, 2024 | 933.34M |
| December 31, 2023 | 940.41M |
| September 30, 2023 | 948.63M |
| June 30, 2023 | 956.74M |
| March 31, 2023 | 972.59M |
| December 31, 2022 | 1.002B |
| September 30, 2022 | 1.008B |
| June 30, 2022 | 1.031B |
| March 31, 2022 | 1.052B |
| December 31, 2021 | 1.050B |
| September 30, 2021 | 1.064B |
| June 30, 2021 | 1.044B |
| March 31, 2021 | 1.023B |
| December 31, 2020 | 1.006B |
| September 30, 2020 | 994.51M |
| June 30, 2020 | 995.73M |
| March 31, 2020 | 779.72M |
| December 31, 2019 | 818.40M |
| Date | Value |
|---|---|
| September 30, 2019 | 307.44M |
| June 30, 2019 | 302.08M |
| March 31, 2019 | 228.04M |
| December 31, 2018 | 206.97M |
| September 30, 2018 | 190.50M |
| June 30, 2018 | 171.09M |
| March 31, 2018 | 163.35M |
| December 31, 2017 | 165.84M |
| September 30, 2017 | 152.61M |
| June 30, 2017 | 145.53M |
| March 31, 2017 | 137.90M |
| December 31, 2016 | 134.37M |
| September 30, 2016 | 129.25M |
| June 30, 2016 | 124.10M |
| March 31, 2016 | 116.32M |
| December 31, 2015 | 116.66M |
| September 30, 2015 | 117.68M |
| June 30, 2015 | 128.17M |
| March 31, 2015 | 28.25M |
| December 31, 2014 | 26.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
779.72M
Minimum
Mar 2020
1.064B
Maximum
Sep 2021
973.32M
Average
995.12M
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| Baxter International Inc | 26.68B |
| Masimo Corp | 3.088B |
| Teleflex Inc | 7.486B |
| Perspective Therapeutics Inc | 391.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 258.03M |
| Shareholders Equity (Quarterly) | 668.51M |
| Debt to Equity Ratio | 0.0849 |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.63% |